The impact factor will absolutely drop this year. The real-time impact factor is more than 11, and it may be around 12 in June.

(0) Thank | 顺子

Blood is an authoritative journal in the field of hematology, and in recent years, the readership and impact factor have been gradually rising. All relevant and highly-regarded publications on blood tumors are published in this journal. Other journals, such as the Journal of Solid Tumors, The Lancet Onocology, and JCO, do not publish relevant articles that frequently.

(1) Thank | Anonymous

Is there any external audit opinion?

(0) Thank | 冠羽mm

It has been two weeks.

(0) Thank | 一吃就胖小阳阳

On the day of submission, is "under review" in Blood referring to an internal review or an external review?

(0) Thank | 一吃就胖小阳阳

Will there be an email for sending out for audit?

(0) Thank | 黯然佳惠

Carry me, god

(0) Thank | 碧桃含文

As for novel cases related to pathology, such as work images in hematology, the cases seen in daily work are very brief. I have seen many published cases. How long will it take to have information about this?

(0) Thank | 玉景俊贤

Submission rate: 5.0
Sharing experiences: Just received an article. It feels really challenging! I specialize in HBV-HCC for my Master's and Ph.D., and have also published several articles. I only started getting involved in blood diseases two years ago due to work reasons. Submitted on 2022-01-11, had the first chance for revision on 2022-02-03, which took three months. With three reviewers, although their feedback was positive, I had to conduct a lot of experiments on mice. The second revision was on 2022-05-23, and only one reviewer had issues. I requested an additional month from the journal to conduct extensive mouse experiments. Submitted again on 2022-07-22 and finally accepted on 2022-08-04. Many thanks to the associate editor and the three reviewers, as they raised important questions that greatly improved the quality of the article. BLOOD, truly a leading journal in blood diseases. Two words to describe the experience: really difficult

(0) Thank | 白云邵美

Just received an article. It feels really not easy! I am doing research on HBV-HCC for my master's and PhD, and have also published a few papers. Two years ago, I only started to work on blood diseases due to work reasons. Submitted on 2022-01-11, received the first round of revisions on 2022-02-03, three months later. There were three reviewers, all positive, but many mouse experiments needed to be added. The second round of revisions was completed on 2022-05-23, and only one reviewer still had issues, so I applied for an extra month from the journal and added a large number of mouse experiments. Resubmitted on 2022-07-22. Accepted on 2022-08-04. Many thanks to the associate editor and the three reviewers, they raised important questions that greatly improved the quality of the article. BLOOD, truly the top journal in hematology. Two words to describe the experience: truly difficult

(0) Thank | 白云邵美

The manuscript number for 2022 has already reached 20,000

(0) Thank | 魔都小柔

Use Average() to calculate the mean, use STDEV.S() to calculate the standard deviation SD, and use STDEV.S()/COUNT()^0.5 to calculate the standard error SEM

(0) Thank | 维尔娜菲茨杰拉德

Plot error bars using ggplot2/excel. In Excel, right-click on the bars, select Format Data Series, click on Error Bars, then select Custom

(0) Thank | 维尔娜菲茨杰拉德

How to calculate margin of error?

(0) Thank | Darlene Pepys

What should I do if error bars are missing on a bar chart?

(0) Thank | 修然小公主

Give him a refund

(0) Thank | 天神院梦凝

Submission success rate: 5.0 | Review fee: $75.0Emphasis on research direction: pediatric experience sharing: No response after submitting in the past, was instantly rejected after paying the $75 review fee

(0) Thank | 云来采蕊

Thank you very much for sending your manuscript, referenced above, to Blood. Your paper was carefully reviewed at the editorial level; and while we agree that your work is interesting, we regret to inform you that we will be unable to consider it for publication. The journal does not generally publish single clinical case reports.

Because of high submission rates, Blood can publish only a fraction of the papers received. As a result, a priority system for publication has been established, based not only on quality of the work, but also on relevance to hematology; the definitive and novel nature of the findings reported; and other factors, both intrinsic and relative to other papers submitted to Blood for consideration. We recognize that many good papers are not selected for publication in Blood.

We hope that our expedited editorial decision will allow you to submit your work to another journal with minimal delay.

We greatly appreciate your interest in publishing in Blood.

Sincerely

(0) Thank | 回风念南

No charge

(0) Thank | 回风念南

No mail means audit failure

(0) Thank | 玄冰迎山

External Auditing

(0) Thank | Norma Raymond

Could you please confirm if the status after QC is always "under review"? Will there be any email notification or status change if it is sent for external review (such as changing from "under review" to "peer review")?

(0) Thank | 蓬莱山甘雨

Could you please translate the following passage into English and Japanese, using titles ":" and ":"?

(0) Thank | 猫巷少女筠溪

I can't remember the feedback on the 18th audit that was submitted

(0) Thank | 玄冰迎山

How long after the internal audit is the external audit conducted?

(0) Thank | 北国紫文